CD274 and neoplasm: It is intriguing to imagine the potential of adding to the present amount of clinical data – just a touch of more complex tumor biology with more in-depth features such as genomic alterations or signatures to predict the suitability of immune-based therapies, PD-L1 expression, mutational burden, and other.